UpHealth, Inc. (NYSE: UPH) Stock Competitors & Peer Comparison

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, GEHC has a market cap of 33.3B. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while GEHC trades at $73.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas GEHC's P/E ratio is 16.18. In terms of profitability, UPH's ROE is -1.05%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, UPH is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for UPH.Check GEHC's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while GEHCV trades at $56.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas GEHCV's P/E ratio is N/A. In terms of profitability, UPH's ROE is -1.05%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, UPH is more volatile compared to GEHCV. This indicates higher risk in terms of short-term price fluctuations for UPH.Check GEHCV's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, BTSG has a market cap of 11.8B. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while BTSG trades at $60.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas BTSG's P/E ratio is 48.57. In terms of profitability, UPH's ROE is -1.05%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, UPH is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for UPH.Check BTSG's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, TEM has a market cap of 9.5B. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while TEM trades at $54.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas TEM's P/E ratio is -108.58. In terms of profitability, UPH's ROE is -1.05%, compared to TEM's ROE of -0.55%. Regarding short-term risk, UPH is more volatile compared to TEM. This indicates higher risk in terms of short-term price fluctuations for UPH.Check TEM's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while SGFY trades at $30.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas SGFY's P/E ratio is 70.91. In terms of profitability, UPH's ROE is -1.05%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, UPH is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for UPH.Check SGFY's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, HQY has a market cap of 8.8B. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while HQY trades at $105.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas HQY's P/E ratio is 24.67. In terms of profitability, UPH's ROE is -1.05%, compared to HQY's ROE of +0.11%. Regarding short-term risk, UPH is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for UPH.Check HQY's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, TXG has a market cap of 7.4B. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while TXG trades at $58.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas TXG's P/E ratio is -342.06. In terms of profitability, UPH's ROE is -1.05%, compared to TXG's ROE of -0.09%. Regarding short-term risk, UPH is more volatile compared to TXG. This indicates higher risk in terms of short-term price fluctuations for UPH.Check TXG's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, HNGE has a market cap of 6.8B. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while HNGE trades at $87.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas HNGE's P/E ratio is 46.68. In terms of profitability, UPH's ROE is -1.05%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, UPH is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for UPH.Check HNGE's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while RCM trades at $14.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas RCM's P/E ratio is -102.21. In terms of profitability, UPH's ROE is -1.05%, compared to RCM's ROE of +0.00%. Regarding short-term risk, UPH is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for UPH.Check RCM's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, DOCS has a market cap of 5B. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while DOCS trades at $26.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas DOCS's P/E ratio is 17.38. In terms of profitability, UPH's ROE is -1.05%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, UPH is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for UPH.Check DOCS's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, WAY has a market cap of 4.8B. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while WAY trades at $25.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas WAY's P/E ratio is 16.61. In terms of profitability, UPH's ROE is -1.05%, compared to WAY's ROE of +0.04%. Regarding short-term risk, UPH is more volatile compared to WAY. This indicates higher risk in terms of short-term price fluctuations for UPH.Check WAY's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while ONEM trades at $16.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas ONEM's P/E ratio is -7.77. In terms of profitability, UPH's ROE is -1.05%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, UPH is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for UPH.Check ONEM's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, PRVA has a market cap of 2.7B. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while PRVA trades at $21.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas PRVA's P/E ratio is 103.62. In terms of profitability, UPH's ROE is -1.05%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, UPH is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for UPH.Check PRVA's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, HTFL has a market cap of 2.7B. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while HTFL trades at $31.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas HTFL's P/E ratio is -15.43. In terms of profitability, UPH's ROE is -1.05%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, UPH is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for UPH.Check HTFL's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, WGS has a market cap of 2.4B. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while WGS trades at $79.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas WGS's P/E ratio is 219.86. In terms of profitability, UPH's ROE is -1.05%, compared to WGS's ROE of -0.39%. Regarding short-term risk, UPH is more volatile compared to WGS. This indicates higher risk in terms of short-term price fluctuations for UPH.Check WGS's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, PGNY has a market cap of 2B. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while PGNY trades at $25.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas PGNY's P/E ratio is 18.76. In terms of profitability, UPH's ROE is -1.05%, compared to PGNY's ROE of +0.16%. Regarding short-term risk, UPH is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for UPH.Check PGNY's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while NXGN trades at $23.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas NXGN's P/E ratio is -266.00. In terms of profitability, UPH's ROE is -1.05%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, UPH is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for UPH.Check NXGN's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while OMDA trades at $24.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas OMDA's P/E ratio is 348.14. In terms of profitability, UPH's ROE is -1.05%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, UPH is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for UPH.Check OMDA's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while AGTI trades at $10.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas AGTI's P/E ratio is -71.79. In terms of profitability, UPH's ROE is -1.05%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, UPH is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for UPH.Check AGTI's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, GDRX has a market cap of 1.3B. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while GDRX trades at $3.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas GDRX's P/E ratio is 11.63. In terms of profitability, UPH's ROE is -1.05%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, UPH is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for UPH.Check GDRX's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, CERT has a market cap of 1.3B. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while CERT trades at $8.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas CERT's P/E ratio is 20.38. In terms of profitability, UPH's ROE is -1.05%, compared to CERT's ROE of -0.07%. Regarding short-term risk, UPH is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for UPH.Check CERT's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, TDOC has a market cap of 1.3B. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while TDOC trades at $6.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas TDOC's P/E ratio is -7.72. In terms of profitability, UPH's ROE is -1.05%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, UPH is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for UPH.Check TDOC's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while CCLDO trades at $27.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas CCLDO's P/E ratio is N/A. In terms of profitability, UPH's ROE is -1.05%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, UPH is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for UPH.Check CCLDO's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, HSTM has a market cap of 847.8M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while HSTM trades at $29.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas HSTM's P/E ratio is 35.83. In terms of profitability, UPH's ROE is -1.05%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, UPH is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for UPH.Check HSTM's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, PHR has a market cap of 779.4M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while PHR trades at $12.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas PHR's P/E ratio is 45.04. In terms of profitability, UPH's ROE is -1.05%, compared to PHR's ROE of +0.03%. Regarding short-term risk, UPH is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for UPH.Check PHR's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, CTEV has a market cap of 719.4M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while CTEV trades at $42.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas CTEV's P/E ratio is -2.48. In terms of profitability, UPH's ROE is -1.05%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, UPH is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for UPH.Check CTEV's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, SOPH has a market cap of 639.3M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while SOPH trades at $7.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas SOPH's P/E ratio is -6.86. In terms of profitability, UPH's ROE is -1.05%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, UPH is more volatile compared to SOPH. This indicates higher risk in terms of short-term price fluctuations for UPH.Check SOPH's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while MPLN-WT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, UPH's ROE is -1.05%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, UPH is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for UPH.Check MPLN-WT's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while ACCD trades at $7.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas ACCD's P/E ratio is -3.08. In terms of profitability, UPH's ROE is -1.05%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, UPH is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for UPH.Check ACCD's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while SHCR trades at $1.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas SHCR's P/E ratio is -3.76. In terms of profitability, UPH's ROE is -1.05%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, UPH is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for UPH.Check SHCR's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, EVH has a market cap of 525.3M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while EVH trades at $4.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas EVH's P/E ratio is 35.92. In terms of profitability, UPH's ROE is -1.05%, compared to EVH's ROE of -0.99%. Regarding short-term risk, UPH is more volatile compared to EVH. This indicates higher risk in terms of short-term price fluctuations for UPH.Check EVH's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, NRC has a market cap of 480.3M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while NRC trades at $21.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas NRC's P/E ratio is 25.99. In terms of profitability, UPH's ROE is -1.05%, compared to NRC's ROE of +0.48%. Regarding short-term risk, UPH is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for UPH.Check NRC's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while SLGC trades at $2.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas SLGC's P/E ratio is -3.04. In terms of profitability, UPH's ROE is -1.05%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, UPH is more volatile compared to SLGC. This indicates higher risk in terms of short-term price fluctuations for UPH.Check SLGC's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while SLGCW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, UPH's ROE is -1.05%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, UPH is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for UPH.Check SLGCW's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while TBRG trades at $26.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas TBRG's P/E ratio is 9.37. In terms of profitability, UPH's ROE is -1.05%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, UPH is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for UPH.Check TBRG's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while MPLN trades at $23.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas MPLN's P/E ratio is -0.23. In terms of profitability, UPH's ROE is -1.05%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, UPH is more volatile compared to MPLN. This indicates higher risk in terms of short-term price fluctuations for UPH.Check MPLN's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, SY has a market cap of 288.7M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while SY trades at $2.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas SY's P/E ratio is -6.67. In terms of profitability, UPH's ROE is -1.05%, compared to SY's ROE of -0.16%. Regarding short-term risk, UPH is more volatile compared to SY. This indicates higher risk in terms of short-term price fluctuations for UPH.Check SY's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while TRHC trades at $10.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas TRHC's P/E ratio is -4.27. In terms of profitability, UPH's ROE is -1.05%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, UPH is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for UPH.Check TRHC's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while SMFR trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas SMFR's P/E ratio is N/A. In terms of profitability, UPH's ROE is -1.05%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, UPH is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for UPH.Check SMFR's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, SPOK has a market cap of 229.8M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while SPOK trades at $11.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas SPOK's P/E ratio is 18.33. In terms of profitability, UPH's ROE is -1.05%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, UPH is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for UPH.Check SPOK's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, AMWL has a market cap of 219.9M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while AMWL trades at $12.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas AMWL's P/E ratio is -2.93. In terms of profitability, UPH's ROE is -1.05%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, UPH is more volatile compared to AMWL. This indicates higher risk in terms of short-term price fluctuations for UPH.Check AMWL's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, OPRX has a market cap of 164.8M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while OPRX trades at $8.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas OPRX's P/E ratio is 8.06. In terms of profitability, UPH's ROE is -1.05%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, UPH is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for UPH.Check OPRX's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while CPSI trades at $9.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas CPSI's P/E ratio is -183.80. In terms of profitability, UPH's ROE is -1.05%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, UPH is more volatile compared to CPSI. This indicates higher risk in terms of short-term price fluctuations for UPH.Check CPSI's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, HCAT has a market cap of 129.3M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while HCAT trades at $1.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas HCAT's P/E ratio is 8.75. In terms of profitability, UPH's ROE is -1.05%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, UPH is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for UPH.Check HCAT's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while AUGX trades at $2.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas AUGX's P/E ratio is -4.99. In terms of profitability, UPH's ROE is -1.05%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, UPH is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for UPH.Check AUGX's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, CCLD has a market cap of 104.1M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while CCLD trades at $2.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas CCLD's P/E ratio is 9.42. In terms of profitability, UPH's ROE is -1.05%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, UPH is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for UPH.Check CCLD's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, WORX has a market cap of 88M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while WORX trades at $5.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas WORX's P/E ratio is -6.40. In terms of profitability, UPH's ROE is -1.05%, compared to WORX's ROE of -0.65%. Regarding short-term risk, UPH is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for UPH.Check WORX's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while FORA trades at $2.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas FORA's P/E ratio is -24.11. In terms of profitability, UPH's ROE is -1.05%, compared to FORA's ROE of -0.17%. Regarding short-term risk, UPH is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for UPH.Check FORA's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, DH has a market cap of 67.6M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while DH trades at $0.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas DH's P/E ratio is 2.46. In terms of profitability, UPH's ROE is -1.05%, compared to DH's ROE of -0.75%. Regarding short-term risk, UPH is more volatile compared to DH. This indicates higher risk in terms of short-term price fluctuations for UPH.Check DH's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while CCLDP trades at $19.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas CCLDP's P/E ratio is N/A. In terms of profitability, UPH's ROE is -1.05%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, UPH is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for UPH.Check CCLDP's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, ONMD has a market cap of 44.3M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while ONMD trades at $0.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas ONMD's P/E ratio is -5.18. In terms of profitability, UPH's ROE is -1.05%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, UPH is more volatile compared to ONMD. This indicates higher risk in terms of short-term price fluctuations for UPH.Check ONMD's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while SNCE trades at $5.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas SNCE's P/E ratio is -0.27. In terms of profitability, UPH's ROE is -1.05%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, UPH is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for UPH.Check SNCE's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while AKLI trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas AKLI's P/E ratio is -0.71. In terms of profitability, UPH's ROE is -1.05%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, UPH is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for UPH.Check AKLI's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while SHLT trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas SHLT's P/E ratio is -3.87. In terms of profitability, UPH's ROE is -1.05%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, UPH is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for UPH.Check SHLT's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while SHCRW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, UPH's ROE is -1.05%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, UPH is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for UPH.Check SHCRW's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, ONMDW has a market cap of 32M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while ONMDW trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas ONMDW's P/E ratio is N/A. In terms of profitability, UPH's ROE is -1.05%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, UPH is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for UPH.Check ONMDW's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while STRM trades at $5.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas STRM's P/E ratio is -2.40. In terms of profitability, UPH's ROE is -1.05%, compared to STRM's ROE of -0.65%. Regarding short-term risk, UPH is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for UPH.Check STRM's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while RNLX trades at $0.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas RNLX's P/E ratio is -0.33. In terms of profitability, UPH's ROE is -1.05%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, UPH is more volatile compared to RNLX. This indicates higher risk in terms of short-term price fluctuations for UPH.Check RNLX's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while LIFW trades at $3.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas LIFW's P/E ratio is -0.02. In terms of profitability, UPH's ROE is -1.05%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, UPH is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for UPH.Check LIFW's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, SCNX has a market cap of 18.9M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while SCNX trades at $0.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas SCNX's P/E ratio is -0.19. In terms of profitability, UPH's ROE is -1.05%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, UPH is more volatile compared to SCNX. This indicates higher risk in terms of short-term price fluctuations for UPH.Check SCNX's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while BBLN trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas BBLN's P/E ratio is -0.04. In terms of profitability, UPH's ROE is -1.05%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, UPH is more volatile compared to BBLN. This indicates higher risk in terms of short-term price fluctuations for UPH.Check BBLN's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, BEATW has a market cap of 12.5M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while BEATW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas BEATW's P/E ratio is -0.03. In terms of profitability, UPH's ROE is -1.05%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, UPH is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for UPH.Check BEATW's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, BFRG has a market cap of 10.8M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while BFRG trades at $0.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas BFRG's P/E ratio is -1.08. In terms of profitability, UPH's ROE is -1.05%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, UPH is more volatile compared to BFRG. This indicates higher risk in terms of short-term price fluctuations for UPH.Check BFRG's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while ETAO trades at $1.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas ETAO's P/E ratio is -0.01. In terms of profitability, UPH's ROE is -1.05%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, UPH is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for UPH.Check ETAO's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, MGRX has a market cap of 9M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while MGRX trades at $0.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas MGRX's P/E ratio is -0.39. In terms of profitability, UPH's ROE is -1.05%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, UPH is more volatile compared to MGRX. This indicates higher risk in terms of short-term price fluctuations for UPH.Check MGRX's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while UPH-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, UPH's ROE is -1.05%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, UPH is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for UPH.Check UPH-WT's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while PEARW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas PEARW's P/E ratio is -0.00. In terms of profitability, UPH's ROE is -1.05%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, UPH is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for UPH.Check PEARW's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while PEAR trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas PEAR's P/E ratio is -0.08. In terms of profitability, UPH's ROE is -1.05%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, UPH is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for UPH.Check PEAR's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while OTRK trades at $0.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas OTRK's P/E ratio is -0.02. In terms of profitability, UPH's ROE is -1.05%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, UPH is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for UPH.Check OTRK's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, HCTI has a market cap of 2M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while HCTI trades at $1.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas HCTI's P/E ratio is -0.22. In terms of profitability, UPH's ROE is -1.05%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, UPH is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for UPH.Check HCTI's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while CMAX trades at $0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas CMAX's P/E ratio is -0.00. In terms of profitability, UPH's ROE is -1.05%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, UPH is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for UPH.Check CMAX's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, VSEEW has a market cap of 1.4M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while VSEEW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, UPH's ROE is -1.05%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, UPH is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for UPH.Check VSEEW's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while ACON trades at $2.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas ACON's P/E ratio is -0.27. In terms of profitability, UPH's ROE is -1.05%, compared to ACON's ROE of -0.59%. Regarding short-term risk, UPH is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for UPH.Check ACON's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while LIFWZ trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, UPH's ROE is -1.05%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, UPH is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for UPH.Check LIFWZ's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, EUDAW has a market cap of 1.1M. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while EUDAW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas EUDAW's P/E ratio is 0.04. In terms of profitability, UPH's ROE is -1.05%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, UPH is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for UPH.Check EUDAW's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, VSEE has a market cap of 816.5K. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while VSEE trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas VSEE's P/E ratio is -0.10. In terms of profitability, UPH's ROE is -1.05%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, UPH is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for UPH.Check VSEE's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while MSPRZ trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, UPH's ROE is -1.05%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, UPH is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for UPH.Check MSPRZ's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while KERN trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas KERN's P/E ratio is -0.01. In terms of profitability, UPH's ROE is -1.05%, compared to KERN's ROE of -0.20%. Regarding short-term risk, UPH is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for UPH.Check KERN's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while KERNW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas KERNW's P/E ratio is -0.00. In terms of profitability, UPH's ROE is -1.05%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, UPH is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for UPH.Check KERNW's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while LIFWW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas LIFWW's P/E ratio is N/A. In terms of profitability, UPH's ROE is -1.05%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, UPH is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for UPH.Check LIFWW's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while CMAXW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas CMAXW's P/E ratio is N/A. In terms of profitability, UPH's ROE is -1.05%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, UPH is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for UPH.Check CMAXW's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, ZCMD has a market cap of 35.3K. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while ZCMD trades at $1.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, UPH's ROE is -1.05%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, UPH is more volatile compared to ZCMD. This indicates higher risk in terms of short-term price fluctuations for UPH.Check ZCMD's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, ACONW has a market cap of 16K. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while ACONW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas ACONW's P/E ratio is N/A. In terms of profitability, UPH's ROE is -1.05%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, UPH is less volatile compared to ACONW. This indicates lower risk in terms of short-term price fluctuations for UPH.Check ACONW's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, WGSWW has a market cap of 5.8K. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while WGSWW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas WGSWW's P/E ratio is -0.00. In terms of profitability, UPH's ROE is -1.05%, compared to WGSWW's ROE of -0.39%. Regarding short-term risk, UPH is more volatile compared to WGSWW. This indicates higher risk in terms of short-term price fluctuations for UPH.Check WGSWW's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while CSLT trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas CSLT's P/E ratio is -37.27. In terms of profitability, UPH's ROE is -1.05%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, UPH is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for UPH.Check CSLT's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while MTBCO trades at $25.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas MTBCO's P/E ratio is N/A. In terms of profitability, UPH's ROE is -1.05%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, UPH is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for UPH.Check MTBCO's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while MTBC trades at $3.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas MTBC's P/E ratio is N/A. In terms of profitability, UPH's ROE is -1.05%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, UPH is more volatile compared to MTBC. This indicates higher risk in terms of short-term price fluctuations for UPH.Check MTBC's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while CNVY trades at $10.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas CNVY's P/E ratio is -71.50. In terms of profitability, UPH's ROE is -1.05%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, UPH is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for UPH.Check CNVY's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while MSPRV trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas MSPRV's P/E ratio is N/A. In terms of profitability, UPH's ROE is -1.05%, compared to MSPRV's ROE of N/A. Regarding short-term risk, UPH is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for UPH.Check MSPRV's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, KURIU has a market cap of 0. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while KURIU trades at $9.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas KURIU's P/E ratio is N/A. In terms of profitability, UPH's ROE is -1.05%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, UPH is more volatile compared to KURIU. This indicates higher risk in terms of short-term price fluctuations for UPH.Check KURIU's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while MTBCP trades at $26.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas MTBCP's P/E ratio is N/A. In terms of profitability, UPH's ROE is -1.05%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, UPH is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for UPH.Check MTBCP's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while CHNG trades at $27.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas CHNG's P/E ratio is -152.72. In terms of profitability, UPH's ROE is -1.05%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, UPH is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for UPH.Check CHNG's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while CHNGU trades at $73.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas CHNGU's P/E ratio is N/A. In terms of profitability, UPH's ROE is -1.05%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, UPH is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for UPH.Check CHNGU's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, NH has a market cap of 0. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while NH trades at $1.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas NH's P/E ratio is -0.12. In terms of profitability, UPH's ROE is -1.05%, compared to NH's ROE of +0.35%. Regarding short-term risk, UPH is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for UPH.Check NH's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, IMS has a market cap of 0. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while IMS trades at $31.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas IMS's P/E ratio is N/A. In terms of profitability, UPH's ROE is -1.05%, compared to IMS's ROE of +0.27%. Regarding short-term risk, UPH is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for UPH.Check IMS's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while NAVA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas NAVA's P/E ratio is N/A. In terms of profitability, UPH's ROE is -1.05%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, UPH is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for UPH.Check NAVA's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, CERN has a market cap of 0. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while CERN trades at $94.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas CERN's P/E ratio is 55.84. In terms of profitability, UPH's ROE is -1.05%, compared to CERN's ROE of +0.14%. Regarding short-term risk, UPH is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for UPH.Check CERN's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while SMFRW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas SMFRW's P/E ratio is N/A. In terms of profitability, UPH's ROE is -1.05%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, UPH is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for UPH.Check SMFRW's competition here

UpHealth, Inc. (NYSE: UPH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPH stands at 5.3M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, UPH is priced at $0.30 on the NYSE, while AFFX trades at $14.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPH currently has a P/E ratio of -0.07, whereas AFFX's P/E ratio is N/A. In terms of profitability, UPH's ROE is -1.05%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, UPH is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for UPH.Check AFFX's competition here